Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Gadopiclenol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EU Approves Guerbet's Half-Dose Elucirem for Kids
    EU Approves Guerbet's Half-Dose Elucirem for Kids

    27 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-indication-in-children-from-birth-for-guerbets-half-dose-gbca-elucirem-gadopiclenol-approved-by-european-commission-302671258.html

    PR NEWSWIRE
    27 Jan 2026
    Share Share
    EU Extends Vueway Approval for Pediatric Patients Under 2 year
    EU Extends Vueway Approval for Pediatric Patients Under 2 year

    27 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-european-commission-extended-the-marketing-authorisation-for-vueway-r-gadopiclenol-in-the-european-union-for-use-in-pediatric-patients-under-2-years-of-age-877772583.html

    PR NEWSWIRE
    27 Jan 2026
    Share Share
    Bracco Diagnostics Achieves 1 Million Injections of VUEWAY®
    Bracco Diagnostics Achieves 1 Million Injections of VUEWAY®

    11 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bracco-diagnostics-inc-obtains-hallmark-achievement-of-one-million-injections-with-its-mri-agent-vueway-gadopiclenol-solution-for-injection-302300316.html

    PR NEWSWIRE
    11 Nov 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.